+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)


Global Neurovascular Devices Market - Forecasts from 2018 to 2023

  • ID: 4661662
  • Report
  • Region: Global
  • 103 pages
  • Knowledge Sourcing Intelligence LLP
until Dec 31st 2019
1 of 4


  • Acandis GmbH
  • Johnson & Johnson
  • Memry Corporation
  • MicroVention inc.
  • Penumbra, Inc.
  • Phenox GmbH
  • MORE
Global neurovascular devices market is projected to witness a CAGR of 6.83% over the forecast period of 2017-2023. Neurovascular devices are used as an aid in the treatment of the various neurovascular disorders such as brain aneurysms, arteriovenous malformations (AVMs) and carotid artery disease. Growth in the market may be attributed to the upsurge in the number of patients suffering from neurovascular diseases and also rising preference of the minimally invasive devices owing to the quick healing time, less complications and short hospital Stays.

Rising Incidence of the Neurovascular Diseases to Augment the Market Growth

The increasing population coupled with the rising geriatric population at the risk of neurovascular diseases will boost the market for the neurovascular devices during the given time frame. As per the data by Center for Disease Control and Prevention (US), 7.4 million people suffered from stroke in US. Unhealthy lifestyle have increased the prevalence of the diseases such as hypertension, obesity, diabetes and high blood cholesterol which have further raised the chances of cerebrovascular disorders, thus, boosting the growth of the neurovascular devices market for the treatment of the disorders. Advancement in the field of the neurovascular disorder treatment such as the use of embolization for cerebral AVMs and internal carotid artery stenting for intracranial atherosclerotic disease will also bolster the market growth during the forecast period. However, the growth of the market might be restrained due to the high treatment cost and lack of trained professionals.

Asia Pacific to be lucrative market for Neurovascular Devices

Geographically, North America is estimated to hold the major share in the neurovascular devices market. The major factors driving the growth of the market in the region is the growing and quick adoption of the neurovascular devices coupled with the favourable reimbursement policies. Rising aware among the population regarding neurovascular devices will also boost the market in the region. Asia-Pacific will present a lucrative opportunity for the neurovascular devices owing to the rising patient base suffering from diseases such as stenosis, AVM, and strokes along with the improving healthcare infrastructure.

Market intelligence is presented in the form of analysis, charts, and graphics to help the clients in gaining faster and efficient understanding of the global neurovascular devices market.

Major industry players profiled as part of the report are Penumbra, Inc., Stryker and Phenox GmbH among others.


By Type

Neurovascular Access Devices
Angioplasty and Stenting Devices
Embolization Devices
Neurothrombectomy Devices

By Indication

Arteriovenous Malformation (AVM)

By End-users

Ambulatory Surgical Centers

By Geography

North America


South America


Middle East and Africa
Saudi Arabia

Asia Pacific
South Korea
Note: Product cover images may vary from those shown
2 of 4


  • Acandis GmbH
  • Johnson & Johnson
  • Memry Corporation
  • MicroVention inc.
  • Penumbra, Inc.
  • Phenox GmbH
  • MORE
1. Introduction
1.1. Market Definition
1.2. Scope of the Study
1.3. Currency
1.4. Assumptions
1.5. Base, and Forecast Years Timeline

2. Research Methodology
2.1. Research Design
2.2. Secondary Sources
2.3. Validation

3. Key Findings of the Study

4. Market Dynamics
4.1. Drivers
4.2. Restraints
4.3. Opportunities and Market Trends
4.4. Market Segmentation
4.5. Porter’s Five Forces Analysis
4.5.1. Bargaining Power of Suppliers
4.5.2. Bargaining Power of Buyers
4.5.3. Threat of New Entrants
4.5.4. Threat of Substitutes
4.5.5. Competitive Rivalry in the Industry
4.6. Industry Value Chain Analysis
4.7. Industry Regulations
4.8. Scenario Analysis

5. Global Neurovascular Devices Market Forecast by Type
5.1. Neurovascular Access Devices
5.2. Angioplasty and Stenting Devices
5.3. Embolization Devices
5.4. Neurothrombectomy Devices

6. Global Neurovascular Devices Market Forecast by Application
6.1. Stroke
6.2. Arteriovenous Malformation (AVM)
6.3. Aneurysms
6.4. Stenosis
6.5. Others

7. Global Neurovascular Devices Market Forecast by End-User
7.1. Hospitals
7.2. Ambulatory Surgical Centres

8. Global Neurovascular Devices Market Forecast by Geography
8.1. North America
8.1.1. The U.S
8.1.2. Canada
8.1.3. Mexico
8.1.4. Others
8.2. South America
8.2.1. Brazil
8.2.2. Argentina
8.2.3. Others
8.3. Europe
8.3.1. U.K.
8.3.2. France
8.3.3. Germany
8.3.4. Italy
8.3.5. Others
8.4. Middle East and Africa
8.4.1. Saudi Arabia
8.4.2. UAE
8.4.3. Israel
8.5. Asia Pacific
8.5.1. China
8.5.2. India
8.5.3. Japan
8.5.4. South Korea
8.5.5. Others

9. Competitive intelligence
9.1. Market Share Analysis
9.2. Strategies of Key Players
9.3. Recent Investments and Deals

10. Company Profiles
10.1. Penumbra, Inc.
10.1.1. Overview
10.1.2. Financials
10.1.3. Product and Services
10.1.4. Recent Development
10.2. MicroVention Inc.
10.2.1. Overview
10.2.2. Financials
10.2.3. Product and Services
10.2.4. Recent Development
10.3. Stryker
10.3.1. Overview
10.3.2. Financials
10.3.3. Product and Services
10.3.4. Recent Development
10.4. Evasc Neurovascular Enterprises
10.4.1. Overview
10.4.2. Financials
10.4.3. Product and Services
10.4.4. Recent Development
10.5. Acandis GmbH
10.5.1. Overview
10.5.2. Financials
10.5.3. Product and Services
10.5.4. Recent Development
10.6. Memry Corporation
10.6.1. Overview
10.6.2. Financials
10.6.3. Product and Services
10.6.4. Recent Development
10.7. Phenox GmbH
10.7.1. Overview
10.7.2. Financials
10.7.3. Product and Services
10.7.4. Recent Development
10.8. Spartan Micro Inc.
10.8.1. Overview
10.8.2. Financials
10.8.3. Product and Services
10.8.4. Recent Development
10.9. Johnson & Johnson
10.9.1. Overview
10.9.2. Financials
10.9.3. Product and Services
10.9.4. Recent Development
10.10. Shape Memory Medical Inc.
10.10.1. Overview
10.10.2. Financials
10.10.3. Product and Services
10.10.4. Recent Development
Note: Product cover images may vary from those shown
3 of 4


4 of 4
  • Penumbra, Inc.
  • MicroVention inc.
  • Stryker
  • Evasc Neurovascular Enterprises
  • Acandis GmbH
  • Memry Corporation
  • Phenox GmbH
  • Spartan micro inc.
  • Johnson & Johnson
  • Shape Memory Medical Inc.
Note: Product cover images may vary from those shown
5 of 4

The research study is based on the publisher's proprietary research model. The process involves sourcing of information from various industry experts, key professionals, decision-makers and various other stakeholders along with the validation of the responses received from the vast in-house database and premium paid databases. Publicly available sources were also taken into consideration for the final market estimates and forecast for the segments and sub-segments.

The first phase of the research process is the identification of key industry leaders, experts, decision-makers and C-level executives and then conducting interviews and surveys to gain vital insights about the market. Simultaneously, extensive secondary research is done, and key secondary data is collected as part of this process. This secondary data is collected from various databases, industry journals, whitepapers, company annual reports, research publications, and other paid data sources and relevant literature. Company profiles which include strategies, new product developments, recent investments, major products and services, financials and business plans are sourced from the annual reports, SEC filings, industry associations to preserve the quality of the information being displayed. The findings from both the primary and the secondary research process combined go under further processing for market breakdown and forecasting.

The last phase is providing intelligence in the form of presentation, charts, graphics and other different formats helping the clients in a faster and efficient understanding of the market. Under this phase complete market engineering is involved which includes analyzing the collected data from different sources and existing proprietary datasets while using various data triangulation methods for market breakdown and forecasting. The publisher has developed their market forecasting methodology that, in addition to the main market values, also takes into account other macroeconomic factors (global or local) that might have some bearing on the market under study. Taking all the necessary data, a robust forecast is developed using an algorithm that involves both static (multivariate) as well as dynamic (time-series) regression analysis. Special care is taken to make sure their algorithm passes the necessary statistical tests, and the mean prediction for future years obtained is reliable with a very high confidence level. Following data validation, the analysts begin to write the report presenting insights with the help of charts, graphs, and tables.